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a greater increase in LVEF in 66 pts (from !Zyo to 63%) than did no P in
65 pte (from 58% to 60%) (p < 0.0001). At 1 year, P caused a greater
decrease in left ventricular mass (from 312 g to 276 g) than did no P
(from 317 g to 297 g) (p = 0.0001). Multivariate Cox regression analysis
for mortality including variables age, sex, hypertension, atrial fibrillation,
baseline LVEF,baseline Ieftventricular mass, and Pshowed that independent
variables for death were age (risk ratio = 1.061), baseline LVEF (risk ratio
= 0.969}, and P (risk ratio = 0.645). Independent variables for death plus
nonfatal myoeardial infarction were age (risk ratio = 1.060), baseline LVEF
(risk ratio = 0.964), and P (risk ratio = 0.630). Conclusions: In older pts
with heart failure, prior myocardial infarction, and LVEF ? 40Y0 treated with
diuretics plus angiotensin-eonveding-enzyme inhibitors, compared with no
P, P increased LVEF and decreased left ventricular mass, mortality, and
mortality plus nonfatal myocardial infarction.
I 1063-177] Re~p~n~et~P-blockerinElderlYP*tientswith
Severe Heart Failura
M.L. Fisher, S.S. Gottlieb, S.K. Bennett. Urriversityof A4ary/andand
Baffimore VA,Baltimore, MD, USA
Trials of new treatments for patients (pts) with severe chronic heart failure
(CHF) often exclude or have a limited number of elderly subjects, making the
relevance of results to this unique cohort uncertain. In particular, older pts
may respond differently to &blockade than younger pts. Inaddition, clinicians
often avoid f?-blockers in elderly pts because of fear of precipitating CHF.
Hence, we examined tolerance to titrated metoprolol and outcome in a series
of 93 patients (pts) age ? 60 with persistent CHF symptoms despite maximal
standard CHF therapy, NYHA class II = 17, Ill = 35, IV = 37. At baseline,
mean ejection fraction (EF) was 21% + 7%.
In these older, severe CHF pts with a mean age of 67 + 5 years, including
11 pta over 75, metoprolol was well tolerated with only 3 pte (3%) being
intolerant of the drug. Predictably, one year mortality was high (23Yo),but
66 pts (73%) were improved (Jsymptoms and ?EF ? 5) or stable. Overall
frequeneyof marked improvement was40% (32pts), similar toourconcurrent
experience in younger CHFpts and associated with a mean TEF of 18+ 7 (i.e.
mean follow-up EF was 41% in this group). Comparing pts who were stable
or improved to pts who deteriorated (died or were intolerant of metoprolol),
the latter group had lower baseline EF and more severe symptoms (p <
0.05). However, even in the cohort with the most severe CHF (class IV), 12
pte (32%) had mahed improvement.
Our obsenfations suggest that older pts with advanced CHF both tolerate
and often improve with metoprolol. This suppotis the overall safety ofeerefully
titrated p-blocker and justifiea active recruitment of elderly pts for on-going
@-blockerCHFsuwival trials.
Wednesday,March 19, 1997, Noon-2:00 p.m.
AnaheimConventionCenter,Hall E
PresentationHour:Noon–1:00 p.m.
11064-161I Video-AaaiatedCoronaV BYPaasSurgeYWith
internai Mammary Artery: Reauita of a New
Minimaiiy invaaive Surgicai Aiterrtative for
Singie Veaaai Diaeaaa
P.Nataf, L. Lima, F.Jault, S. Benarim, R. Dorent, E. Vaissier,
J.P. Levasseur, A. Pavie, 1.Gandjbakhch. Sce de Chirurgie Cardiaque,
H6pital Piti6, Paris, France
Cliniesi experience with a video-assisted corona!y artery bypass grafting
procedure using the internal mammary artery is reported. The technique
consists of a videoseopic harvesting of the left internal mammary arlery
(LIMA) to revasculartse the left anterior descending artery (LAD) through
a 4 cm left thorecotomy. Between September 1995 and August 1996, we
performed this procedure in 30 patients (Pts) (29 males, 1 female; aged
38-71) with an isolated proximal LAD stenosis (n = 21) or occlusion (n = 9).
All Pts were symptomatic despite appropriate medication. A history of non
transmural myocardial infarction with myocardial viability was found in 9 Pts.
Fourteen Pts had a restenosis after previous PTCA. Mean left ventricular
ejection fraction was 0.61 (< 0.3 in 2 Pts). The LAD-LIMA anastomosis was
performed on the beating heart without cardio-pulmonay bypass (CPB) in 26
Pts. Femoral-femoral CPB was used in 3 Pts becausa unstable angina (n =
1) and intramyoeardial LAD (n = 2). Conversion to aternotomy and standard
CPB was necessary in one Pt for extensive endarterectomy of the LAD.
There were no operative complication and no reoperation for hemorrhage.
Pulmonary infection was observed in 1 Pt and wound infection in 1 Pt. Pts
were ready for discharge on the fifth postoperative day (36 h-13 days).
Control coronary angiography was performed in 17 Pts showing a patent
graft in all cases. An occlusion of the distal segment of the LAD with a
retrograde petfusion of the proximal segment and septal branches by the
LIMA was found in one case. This patient was symptom free and stress test
was negative.Aneetomotic stenosis was noted in 2 Pretreated by angioplasty
(n= 1) and mnventional surgery (n= 1).
In conclusion, the efficiency of this minimally invasive approach should
be prospectively compared to similar reveecularisation with PTCAorsurgieel
approaches using stemotomy with or without CPB.
-] EffeCtsofHeParin Coating ofi3rtracorporeai
Circuits on Raieaea of LPS Toxicity-Modulating
Proteina During Cardiopuimonary Bypaaa
M.G. Bouma, J.G. Maessen, P.W.Weerwind, W.A. Buurman. University of
Limburg and Academic Hospital Maastricht, Maastricht, The Netherlands
Beesuse the pathways leading to the systemic inflammatory response after
cardiopulmonary bypass (CPB) resemble those involved in septic shock, we
determined the releasa into the circulation of three proteins that modulate
the toxic effects of Iipopolysaccharide (LPS), during and after CPB in 14
consecutive patients, using either non-coated (n= 7) or heparin-coated (HC,
n : 7) extracaqmreal circuits (ECC). With non-coated ECC, plasma lev-
els of neutrophil-derived bactericidal/perrneability-increasing protein (BPI, A)
peaked direcllyaftercross (X)-clamp release, and declined rapidly thereafter.
This peak was almost completely prevented by HC. Release of LPS-binding
protein (LBP,B) fitted atypical acute phase response pattern, but was not af-
fected by HC. Post-clamp plasma levels of monocyte-derived soluble CD14
(sCD14, C), a protein involved in LPS binding to cells, were significantly
higher with non-coated ECC.
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Conclusions:HC prevents early contact-activation of neutrophils and
monocytes during CPB, but does not affect the acute phase response. Fur-
thermore, these data point to a possible role of LPS toxicity-modulating
proteins in the pathogenesis of the systemic inflammato~ response after
CPB.
= A0.7%D~pSternai Wound infection Rate in
658 Biiaterai Internal Mammary Artery impianta:
Tha Benefit of Avoiding Eiectro Cautery and
Bone Wax
G.E. Cimochowski, M.D. Harostoek, P. Foldes. The Wilkes-Barre Genera/
Hospital, Wilkes-Barre, PA, USA
One of the most serious disadvantages to the routine use of bilateral internal
mammary arteries (BIMA’s) is the reported increased risk of deep sternal
wound infection. We prospectively analyzed this complication in light of
assiduously avoiding electro cautery to control bleeding in any parl of the
periostial edges of the sternum and simultaneously avoiding bone wax in the
marrow. Grp I consisted of 656 consecutive patients (pts) between 10/1/90
and 4/1/96 implanted with bilateral IMA’s (+) veins who were prospectively
analyzed for deep sternal wound infection. A comparison Grp 11,1,809 pts,
operated on between 10/1/90 and 4/1/96 with one IMA (+) veins was used
as a control.
Resu/ts; The pt population did not differ with respect to sex, redo’s,
elective vs emergenciesor peripheral vascular disease. There were statistical
differenceswith respect to age, diabetes, COPD, perfusion time, cross-clamp
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time and obesity. However, the deep sternal wound infection waa exactly the
same; 0.7Y0(14/1, 809) for one IMA VS0.7% (5/658) for two IMA’s. In the
highest risk subgroup, i.e., diabetes, the overall wound infection rate was
2.4% (3/121) but this again does not differ from diabetics with a single IMA
whose sternal wound infec!ion rate was 1.4% (7/486) (p= 0.48).
Conclusion: The use of bilateral internal mammary arteries using these
dual techniques in pts has a very low overall sternal wound infection 0.7%
(5/566). Importantly, it is exacilytheesme as single IMA’s. In diabetic mellitus
pts it is modestly elevated to2.4% (3/121) but is not statistically different from
single IMA’s with diabetes. Avoiding ebctro cautery and bone wax resolves
the issue of BIMA vs IMA in most instances with regard to deep sternal
infection and results in a minimal deep sternal wound infection rate with or
without diabetes.
[1064-I68I DistindiveHemodynamicFeaturesofthe
Freestyle Aortic Bioprosthesis ss Compared to
Stented Bioprosthesis
J.G. Dumesnil, M.H. LeBlanc, P.Carrier,J. M6tres, D. Desauiniere,
D.P. Doyle, M. Lemieux, G. Raymond. Quebec Heart Institute, Sainte-Fo&
Quebec, Canada
The objective of this study was to evaluate the short, medium and long term
hamodynamic performance of the Freestyle unstentad prosthesis as com-
pared to conventional stentad prosthesis, The study includes 157 patients
(pts) (69 M, 88 F) aged 48t085yeara (mean 69 + 7)operatedforaortic insuf-
ficiency (11 pts), stenosis (58 pts) or mixed disease (88 pts) and prosthesis
size (mm, n pts) were 19 (4), 21 (22), 23 (42), 25 (52), 27 (37). Echocer-
diograms were done early (157 pts), 3-8 months (129 pts), 11-14 months
(99 pts) and 23-25 months (21 pts) afferolx?ration. Distinctive hemodynamic
features of the prosthesis compared to stentad prosthesis are: 1. Hemody-
namice improve significantly during the first 3-6 months (mean gradient –3.5
+ 4.0 mmHg (p < 0.001), effective orifice area (EOA) + 0.15 + 0.26 cm2
(p < 0.05)) and remain stable thereafter. 2. Average mean gradient (6 + 4
mmHg) atone year is markedly lower than in aimilar size stented prosthesis
(e.g. Intact prosthesis =22 + 8 mmHg, Moaai’cprosthesis = 12 + 6 mmHg).
3. In vivo EOA’Sare lower (-O.91 * 0.35 cm2)than EOA’scalculatad in vitro.
As in stentad prosthesis, there is a close correlation (r = 0.77) between EOA
indexed for body surface area and mean gradient but with less evidence of
patient-prosthesis mismatch. Incidence of trivial or mild aortic regurgitation
was similar (e.g. ?%W.vs 29% in Intact prosthesis).
We conclude that the Freestyle prosthesis has better hemodynamics
than stentad bioprosthesis but that distinctive features need to be taken into
account when interpreting echocsrdiographic results,
1064-169 Ventricular Reduction Surgery ss a Treatment
for Idiopathic Dilated Cardiomyopathy
R.L. Kirshner, P.A. Knight, M.A. Thompson, T.S. Antonacci, K. Gardner,
K.M. Rae, E.A. Arazoza. Universifyof Rochestec Rochester General
Hospital, RochesteL NY USA
We report our single center experience with ventricular reduction surgery
for the treatment of non-ischemic dilated cardiomyopathy in 7 patients, all
of whom were ineligible for cardiac transplant. All were symptomatic NYHA
functional class Ill or IV on background therapy consisting of ACE inhibitor,
digoxin, and diuretics. The mean age waa 66. Six patients had concomitant
mitral ano’/ortricuspid valve repair.One patient had mitral valve replacement.
At average 26 days follow-up, there have been no deaths. Compared to
preop, the postoperative mean parameters areas follows: NYHA functional
class improved from 3.9 to 2.7 (p = 0.015). Echocerdiographic derived LVEF
using Simpeon’s rule improved from 21Y0to 34°A (p = 0.015). LVEDD de-
creased from 69 mm to 58 mm (p = 0.006). LVEDVdecreased from 217 cc to
117 cc (p = 0.0003). LVESV decreased from 169 cc to 77 cc (p = 0.00005).
Peak aortic outflow velocity increased from 0.69 to 0.79 (p = 0.10). Mitral
inflow deceleration time increased from 141 ms to 171 ms (p = 0.08). Mitral
regurgitation improved from +2.7 to +1.6 (p = 0.08). Six month follow-up data
including SF36 health survey results will alao be presented.
In summary, ventricular reduction surgety appaars to provide subjective
and objective improvement in the early post-operative pariod in this small
number of patients with nonischemic cardiomyopathy. Larger studies and
longer follow-up is warranted.
m Comparison of ThreeCoronaryBypase Mortality
Prediction Modele: Reeults from the National
Cardiovascular Network
E.D. Petereon, P.D.Mauldin, L.H. Muhlbaier, E.R. DeLong, M.J. Lanzilotta.
Duke University Medica/ Center, Durham, NC, USA, fVationa/
Cardiovascular Network, Atlanta GA, USA
Assessment of risk-adjusted coronary artery bypass surgety (CABG) rnortal-
ily results is an important means of monitoring qualify of care. The National
Cardiovascular Network is a volunteer organization (23 high-volume centers)
dedicated to sharing clinical outcomes data. Using the NCN clinical databaae
(n= 34,521), we compared the predictive accuracy of three publishad CABG
risk-prediction methods: ParSonnet (P), O’Connor (0) and Hannan (H). The
overall NCN in-hospital CABG mortality rate was 3.1% (2.67. in isolated
CABG). Median age was 67 yeare, 29.2% were female, 9.4% had prior
CABG, and 43% had prior Ml. Resu/ts: Tha discriminatory abilities of each
method forpradicting in-hospital mortality were quite similar (area under ROC
curves 0.72-0.74). Below, we display obsetved verswsexpected mortality by
these three methods:
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Conclusions: Existing CABG tisk-prediction models tended to over-pra-
dict mortality in NCN data, particularly in,high risk patients. Validation of risk-
pradiction models should bearequirad step in mmparisons of outcomes data.
m POtt-aCCeSSTWO-VeSealCoronary
Revascularizstion in the Dog
J.1.Farm, WS. Peters, T.A. Burden, J.H. Stevens, M.F. Pompili,
F.L. Rosenfeldt, B.A. Reitz. Stanford University Sctmo/ of Medicirre,
Stanford, CA, USA, Baker Medical Research Institute, Melbourne, Australia
Single-vessel coronary revascularization using port-access technology and
cardiopulmonary bypass (CPB) has been achieved. Using this approach, we
evaluated two-vessel corona~ revascularization with a ‘T-graff’ of an arterial
conduit (superficial femoral artery [SFA]) placed end-to-side to left internal
thoracic artery (LITA) in5 dogs (24 + 3 kg, mean + SD). Under general anes-
thesia and single lung ventilation, LITA was harvested thoracoscopically. A
limited anterior mediastinotomy (5 cm) was made, After heparinization, a
4-6 cm segment of SFA was anastomosed end-to side to LITA. Endovas-
cular CPB system was placed peripherally and CPB instituted. Endoeortic
clamp, inserted via the femoral artery, permitted ascending aoflic occlusion
and infusion of antegrade cardioplegia achieving cardioplegic arrest. The
SFA-obtuse marginal artery anastomosis and LITA-IAD anastomosia were
petiormad. The animals were weaned from-CPB.
Resu/ts: All grafts were patent post-mortem. CPB time: 69 k 13 rein;
aortic clamp time: 4e * 9 min.
Pre CPB Post CPB
Cardiac output(Umin): 2.s* 0.7 2.7+0.5
Wedge pressure(mmHg): 9*1 S*1
Conclusions: Using port-access technology, rotation of the heart is pos-
sible and two-vessel corunary revascularization with a ‘T-graft” can be per-
formed safely in the dog. Multiple vessel coronary artery bypass grafting is
a possible extansion of this approach (using arterial conduits and sequential
grafting).
m1064172 Previous Coronary Anery Surgery Hes Little
Influence on In-Hospital Outcome in Unstable
Angina
J.E. Calvin, B.J. Vandenberg, R.J. March, J.E. Parrillo. Rush Medice/
Co//ege, Chicago, /L, USA
Todetermine whether previous corona~ artery surgery (CAS) independentty
influenced in-hospital outcome after a new episode of unstable angina (UA),
